Ghinea N - Search Results

1

A survey of Australian public attitudes towards funding of high cost cancer medicines.

Ghinea N, Critchley C, Morrell B, Kerridge I, Campbell T, Day R, Gazarian M, Isaacs D, Liauw W, Olver I, Pace J, Pearson S, Salkeld G, Lipworth W. Ghinea N, et al. Health Policy. 2021 Mar;125(3):327-334. doi: 10.1016/j.healthpol.2020.12.002. Epub 2020 Dec 10. Health Policy. 2021. PMID: 33402264

2

Clinicians' Perspective on Implementing Virtual Hospital Care for Low Back Pain: Qualitative Study.

Melman A, Vella SP, Dodd RH, Coombs DM, Richards B, Rogan E, Teng MJ, Maher CG, Ghinea N, Machado GC. Melman A, et al. Among authors: ghinea n. JMIR Rehabil Assist Technol. 2023 Nov 21;10:e47227. doi: 10.2196/47227. JMIR Rehabil Assist Technol. 2023. PMID: 37988140 Free PMC article.

3

No evidence or no alternative? Taking responsibility for off-label prescribing.

Ghinea N, Lipworth W, Kerridge I, Day R. Ghinea N, et al. Intern Med J. 2012 Mar;42(3):247-51. doi: 10.1111/j.1445-5994.2012.02713.x. Intern Med J. 2012. PMID: 22432984 Free article.

4

Ethics & evidence in medical debates: the case of recombinant activated factor VII.

Ghinea N, Lipworth W, Kerridge I, Little M, Day RO. Ghinea N, et al. Hastings Cent Rep. 2014 Mar-Apr;44(2):38-45. doi: 10.1002/hast.287. Epub 2014 Feb 14. Hastings Cent Rep. 2014. PMID: 24532448

5

Evidence, regulation and 'rational' prescribing: the case of gabapentin for neuropathic pain.

Ghinea N, Lipworth W, Kerridge I. Ghinea N, et al. J Eval Clin Pract. 2015 Feb;21(1):28-33. doi: 10.1111/jep.12223. Epub 2014 Jul 2. J Eval Clin Pract. 2015. PMID: 24986307

6

Overcoming entrenched disagreements: the case of misoprostol for post-partum haemorrhage.

Ghinea N, Lipworth W, Little M, Kerridge I, Day R. Ghinea N, et al. Dev World Bioeth. 2015 Apr;15(1):48-54. doi: 10.1111/dewb.12040. Dev World Bioeth. 2015. PMID: 25897445 Review.

7

Propaganda or the cost of innovation? Challenging the high price of new drugs.

Ghinea N, Lipworth W, Kerridge I. Ghinea N, et al. BMJ. 2016 Mar 11;352:i1284. doi: 10.1136/bmj.i1284. BMJ. 2016. PMID: 26968991 Free article. Review. No abstract available.

8

Affordable access to innovative cancer medicines - don't forget the prices.

Ghinea N, Lipworth W. Ghinea N, et al. Med J Aust. 2016 Apr 4;204(6):214-5. doi: 10.5694/mja15.01309. Med J Aust. 2016. PMID: 27031390 Free article. No abstract available.

9

Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.

Ghinea N, Lipworth W, Day R, Hill A, Dore GJ, Danta M. Ghinea N, et al. Lancet. 2017 Mar 25;389(10075):1268-1272. doi: 10.1016/S0140-6736(16)32051-7. Epub 2016 Nov 8. Lancet. 2017. PMID: 27832868 No abstract available.

10

Challenges to the validity of using medicine labels to categorize clinical behavior: An empirical and normative critique of "off-label" prescribing.

Ghinea N, Kerridge I, Little M, Lipworth W. Ghinea N, et al. J Eval Clin Pract. 2017 Jun;23(3):574-581. doi: 10.1111/jep.12673. Epub 2016 Nov 14. J Eval Clin Pract. 2017. PMID: 27859988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters